round 2

Quote
Anonymous said:
Same news here. Saw the Gary Pruden presentation: "Too many people calling on the same accounts", "Energy a separate, exciting growing platform", "Wound closure, mechanicals, hemostats part of a 'general surgery' sales call".

Sad but expected as J&J milked companies over the years to feed Wall Street. Our leaders just keep taking the short term view...

God bless, take care of your families.
Click to expand...

That's the best. It's an "exciting, growing platform" so you're not going to mind if we take this away from you, right? There's no room for exciting or growing anywhere in J&J anymore unless you're talking about class-action suits and recalls. Best of luck to the new owners. I hope they reap the rewards we won't have the opportunity to any longer.
 






I was told by my manager that EWHU, would be ok, and only effect poor performers, that is why he was not looking for a new job. Plus after 11 years j&j would take the high road with the sales team, why are all of the posts negative? We just launched a new size of Interceed.
 


















Anonymous said:
I was told by my manager that EWHU, would be ok, and only effect poor performers, that is why he was not looking for a new job. Plus after 11 years j&j would take the high road with the sales team, why are all of the posts negative? We just launched a new size of Interceed.
Click to expand...

This was a much-needed laugh. We might be f*cked, but at least every division of J&J is f*cked these days. Misery loves company.
 






I am betting that Ethicon Inc and EWHU lays off their entire sales forces and all sales management with the merger. Endo gets cross-trained to sell hernia, suture, EWHU.
 






Anonymous said:
I am betting that Ethicon Inc and EWHU lays off their entire sales forces and all sales management with the merger. Endo gets cross-trained to sell hernia, suture, EWHU.
Click to expand...

Might be the other way around actually. With energy out of the picture, the endo reps with their 3 or 4 accounts are pretty expendable. Doesn't take much to cross train EP reps on trocars an endo cutters.
That said, I think ultimately it will be management that is most affected. I'd guess the sales force will all become full line but with much smaller specialty/procedure specific territories. After the merger there will not be a need for the managers from all of the former companies. Just my opinion.
 


















Anonymous said:
Sound right based on the product Olympus /Gyrus is coming out with.
Click to expand...

Don't hold your breath on that. We might be all messed up, but at least we have (had?) something to sell. WTF happened to us? BSX kicked Cordis's ass and now it looks like Covidien is getting over on us. How long until Synthes gets dominated by Stryker? What a joke.
 
























Anonymous said:
Might be the other way around actually. With energy out of the picture, the endo reps with their 3 or 4 accounts are pretty expendable. Doesn't take much to cross train EP reps on trocars an endo cutters.
That said, I think ultimately it will be management that is most affected. I'd guess the sales force will all become full line but with much smaller specialty/procedure specific territories. After the merger there will not be a need for the managers from all of the former companies. Just my opinion.
Click to expand...

I agree that management and home office will be hit hard, but I also think that reps will be cut left and right. I really think reps will be cut by half if not more. I think reps will be cross trained on all the products and have much smaller territories. But even with the small territories rep will be cut. Do you not? The questions are who and when in 2012?
 






Anonymous said:
I agree that management and home office will be hit hard, but I also think that reps will be cut left and right. I really think reps will be cut by half if not more. I think reps will be cross trained on all the products and have much smaller territories. But even with the small territories rep will be cut. Do you not? The questions are who and when in 2012?
Click to expand...

It depends on which division you are referencing. I think Endo will see some cuts at the rep level. EP has already had a significant head count reduction back in September. I believe EWHU did as well? Endo is the only division that hasn't reduced headcount. I think that will occur in 2012, but I don't see the merger changes until 2013. At that time, I think it will be more management and home office than anything. Who knows though really? I don't even think those making the decisions even know anything yet.
 












Dont you see whats ahead. Fewer reps in the OR . The reps that are left will be service , not based on sales. GPO's want to buy more products from less people thats why JnJ is best positioned for the long term . Its just that the reps are a capital expense and profits over comp. We are truly are market driven company not a sales diven company. Hardest part of teh job is figuring the comp plan to your benifit .
 












Anonymous said:
Agreed. EES has long felt their s**t don't stink and has looked down on EWHU.
Click to expand...

Not necessarily. I think it goes back to the LSH days when everyone wanted to be trained to do the procedure. Since EWHU had the only morcellator available at the time, the reps didn't care who trained them on the procedure, as long as they used their morcellator. So you'd see your EWHU reps promoting Ligasure or Gyrus over Harmonic or Enseal. I get the fact that they just wanted the morcellator business but what pissed off a lot of EES reps was the fact that they wouldn't at least funnel those prospective surgeons to another JNJ company instead of a competitor. Give EES first shot at the surgeons and if doesn't work, then go to another competitor. Unfortunately, that didn't happen in a lot of instances.
 






Anonymous said:
Not necessarily. I think it goes back to the LSH days when everyone wanted to be trained to do the procedure. Since EWHU had the only morcellator available at the time, the reps didn't care who trained them on the procedure, as long as they used their morcellator. So you'd see your EWHU reps promoting Ligasure or Gyrus over Harmonic or Enseal. I get the fact that they just wanted the morcellator business but what pissed off a lot of EES reps was the fact that they wouldn't at least funnel those prospective surgeons to another JNJ company instead of a competitor. Give EES first shot at the surgeons and if doesn't work, then go to another competitor. Unfortunately, that didn't happen in a lot of instances.
Click to expand...

Lots of hard feelings over that, to be sure. That said, there really wasn't any finanical incentive for that to happen. If a surgeon was already using Ligasure or Gyrus, there's nothing in it for the rep to convert that over as well. Just sell the morcellator and be on your way.
 






Top Bottom
Back
Quote